OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
April 26, 2023
Martin Smyth, senior vice-president of Go-To-Market Strategy at MasterControl, discusses gaps in digitalization in the pharma industry.
Alessandro Zannini, sales director, engineering division, Stevanato Group, discusses artificial intelligence and digitalization in the pharma field.
The results found that repeatability testing found all 15 processes to be with in specification for target final concentration.
Mariano Mattei, vice-president of cybersecurity and CISO for Azzur Group, goes in depth about cybersecurity in the pharma field.
April 25, 2023
Emily Moran, senior vice-president of vector manufacturing and supply chain at The Center for Breakthrough Medicines, talks about manufacturing processes for viral vectors in the cell and gene therapy space, and more.
Michael Blackton, senior vice-president of technical operations at Elektrofi, speaks about comparability in cell and gene therapy.
Phil Challis, vice-president of product development at eTheRNA, discusses four of the major challenges in working with mRNA therapeutics.
Aspect Biosystems and Novo Nordisk A/S have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics.
The PharmTech editors are excited to kick off INTERPHEX and take a behind-the-scenes look at Colder Products Company's booth during setup day ahead of the conference.
The leaked study summary found that Carvykti (ciltacabtagene autoleucel) reduced disease progression by 74%.